Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent.

^*Corresponding author for this work

Research output: Contribution to journal › Communication

43 Citations (Web of Science)

Original language	English
Journal	Journal of Investigative Dermatology
DOIs	https://doi.org/10.1038/jid.2012.341
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{83bda1eee8e549af8b073106adefade0,

title = "Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent.",

author = "Selma Ugurel-Becker and A Paschen and Becker, \{J{\"u}rgen Christian\}",

year = "2013",

doi = "10.1038/jid.2012.341",

language = "English",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent.

AU - Paschen, A

A2 - Ugurel-Becker, Selma

A2 - Becker, Jürgen Christian

PY - 2013

Y1 - 2013

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000313668000005

UR - https://pubmed.ncbi.nlm.nih.gov/23318786

U2 - 10.1038/jid.2012.341

DO - 10.1038/jid.2012.341

M3 - Communication

C2 - 23318786

SN - 0022-202X

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

ER -